Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Transpl Infect Dis ; 17(2): 297-302, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25651934

RESUMEN

In recent years, black fungi have been increasingly reported as causing opportunistic infections after solid organ transplantation. Here, we report a case of insidious, relentless, and multifocal Exophiala xenobiotica infection in a kidney transplant recipient that eventually required multiple surgical excisions along with oral and intravenous antifungal combination therapy using liposomal amphotericin B and posaconazole. We compare the present case with all previously reported cases of Exophiala infection after kidney transplantation.


Asunto(s)
Exophiala , Rechazo de Injerto/prevención & control , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Trasplante de Riñón , Infecciones Oportunistas/etiología , Feohifomicosis/etiología , Anciano , Femenino , Humanos , Infecciones Oportunistas/inmunología , Infecciones Oportunistas/patología , Feohifomicosis/inmunología , Feohifomicosis/patología , Receptores de Trasplantes
2.
Am J Transplant ; 14(11): 2515-25, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25155294

RESUMEN

Pretransplant donor biopsy (PTDB)-based marginal donor allocation systems to single or dual renal transplantation could increase the use of organs with Kidney Donor Profile Index (KDPI) in the highest range (e.g. >80 or >90), whose discard rate approximates 50% in the United States. To test this hypothesis, we retrospectively calculated the KDPI and analyzed the outcomes of 442 marginal kidney transplants (340 single transplants: 278 with a PTDB Remuzzi score<4 [median KDPI: 87; interquartile range (IQR): 78-94] and 62 with a score=4 [median KDPI: 87; IQR: 76-93]; 102 dual transplants [median KDPI: 93; IQR: 86-96]) and 248 single standard transplant controls (median KDPI: 36; IQR: 18-51). PTDB-based allocation of marginal grafts led to a limited discard rate of 15% for kidneys with KDPI of 80-90 and of 37% for kidneys with a KDPI of 91-100. Although 1-year estimated GFRs were significantly lower in recipients of marginal kidneys (-9.3, -17.9 and -18.8 mL/min, for dual transplants, single kidneys with PTDB score<4 and =4, respectively; p<0.001), graft survival (median follow-up 3.3 years) was similar between marginal and standard kidney transplants (hazard ratio: 1.20 [95% confidence interval: 0.80-1.79; p=0.38]). In conclusion, PTDB-based allocation allows the safe transplantation of kidneys with KDPI in the highest range that may otherwise be discarded.


Asunto(s)
Supervivencia de Injerto , Riñón , Donantes de Tejidos , Adulto , Anciano , Biopsia , Femenino , Humanos , Riñón/patología , Masculino , Persona de Mediana Edad
3.
Minerva Anestesiol ; 76(11): 961-4, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21102392

RESUMEN

We report on a patient with biliary sepsis due to Vancomycin-resistant Enterococcus faecium (VRE) treated with linezolid (LNZ), who had both hepatic failure and acute kidney injury requiring daily sustained low-efficiency dialysis (SLED), a new intermittent, prolonged diffusive modality of renal replacement therapy for ICU patients. Following cholecystostomy and peritoneal drain insertion, serum, bile and peritoneal fluid serial samples were simultaneously collected for LNZ concentration measurement (chromatography/mass spectrometry). Unusually high serum antibiotic levels (20 mg/L or more) were achieved as early as 36 hours since the start of LNZ administration, owing to relatively low hepatic clearance. Serum LNZ leveled off after commencing SLED, apparently reaching steady state levels. The lowest values of Cmin in bile was 5.86 mg/L; the average serum and bile AUC0-12 over the observation period were 204 mg/L*h and 276 mg/L*h, with a AUC0-24/MIC ratio of 227 h and 307 h, respectively. The excellent biliary pharmacodynamic exposure suggests that standard-dose LNZ might represent a valuable choice in severe biliary infection, even in the presence of hepatic failure, when the patients receive highly efficient modalities of renal replacement therapy.


Asunto(s)
Acetamidas/sangre , Acetamidas/uso terapéutico , Lesión Renal Aguda/tratamiento farmacológico , Antibacterianos/sangre , Antibacterianos/uso terapéutico , Enfermedades de las Vías Biliares/tratamiento farmacológico , Fallo Hepático/tratamiento farmacológico , Oxazolidinonas/sangre , Oxazolidinonas/uso terapéutico , Diálisis Renal , Sepsis/tratamiento farmacológico , Sepsis/metabolismo , APACHE , Lesión Renal Aguda/metabolismo , Anciano , Enfermedades de las Vías Biliares/metabolismo , Colecistectomía , Enterococcus faecium , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Linezolid , Fallo Hepático/metabolismo , Masculino , Resistencia a la Vancomicina
4.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...